Jul 26, 2023
Dr. Regillo describes the results of the phase 3 prospective study of Ranibizumab Port Delivery System (PDS) for the treatment of neovascular AMD.
Regillo C, Berger B, Brooks L, Clark WL, Mittra R, Wykoff CC, Callaway NF, DeGraaf S, Ding HT, Fung AE, Gune S, Le Pogam S, Smith R, Willis JR, Barteselli...
May 9, 2023
Dr. Jason Hsu from Wills Eye Hospital returns to The Retina Channel to discuss his groups' retrospective study of eyes with advanced retinal detachement (PVR grade C or worse) that underwent retinectomy without lensectomy. Their study showed that 75% of these eyes at 3 months (and 68% at 6 months) had single...
Feb 28, 2022
Dr. Kumar discussed his group's prospective study on the comparative outcomes of two different drainage techniques (posterior retinotomy vs PFCL) for repair of rhegmatogenous retina detachment.
Jan 17, 2022
Dr. David Sarraf from UCLA discusses Paracentral Acute Middle Maculopathy (PAMM) and its the ischemic implications.
Wang D, Au A, Duker JS, Sarraf D. PAMM and the ischemic cascade associated with radiation retinopathy. Am J Ophthalmol Case Rep. 2020 Sep 8;20:100918. doi: 10.1016/j.ajoc.2020.100918....
Dec 24, 2021
Dr. Kourous Rezaei reviews the results of the GATHER1 trial on complement C5 inhibition for slowing down progression of geography atrophy in dry AMD.
Jaffe GJ, Westby K, Csaky KG, Monés J, Pearlman JA, Patel SS, Joondeph BC, Randolph J, Masonson H, Rezaei KA. C5 Inhibitor Avacincaptad Pegol for...